Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
E288545-5mg | 5mg | In stock | $147.90 | |
E288545-10mg | 10mg | In stock | $246.90 | |
E288545-25mg | 25mg | In stock | $543.90 | |
E288545-50mg | 50mg | In stock | $939.90 | |
E288545-100mg | 100mg | In stock | $1,533.90 |
Positive allosteric modulator of CB2receptors; activein vivo
Specifications & Purity | Moligand™, ≥98%(HPLC) |
---|---|
Biochemical and Physiological Mechanisms | CB2receptor positive allosteric modulator. EnhancesCP 55940 and 2-Arachidonylglycerol-stimulated binding of [35S]GTPγS to CB2receptors, but has no effect in the absence of agonist. Exhibits antinociceptive effects in an animal model of neuropathic pain. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ALLOSTERIC MODULATOR |
Mechanism of action | Allosteric modulator of CB 2 receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | N-[5-bromo-1-[(4-fluorophenyl)methyl]-4-methyl-2-oxopyridin-3-yl]cycloheptanecarboxamide |
---|---|
INCHI | InChI=1S/C21H24BrFN2O2/c1-14-18(22)13-25(12-15-8-10-17(23)11-9-15)21(27)19(14)24-20(26)16-6-4-2-3-5-7-16/h8-11,13,16H,2-7,12H2,1H3,(H,24,26) |
InChi Key | NSGDYZCDUPSTQT-UHFFFAOYSA-N |
Canonical SMILES | CC1=C(C(=O)N(C=C1Br)CC2=CC=C(C=C2)F)NC(=O)C3CCCCCC3 |
Isomeric SMILES | CC1=C(C(=O)N(C=C1Br)CC2=CC=C(C=C2)F)NC(=O)C3CCCCCC3 |
PubChem CID | 137553165 |
Molecular Weight | 435.33 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
F2307390 | Certificate of Analysis | May 08, 2023 | E288545 |
F2307393 | Certificate of Analysis | May 08, 2023 | E288545 |
F2307394 | Certificate of Analysis | May 08, 2023 | E288545 |
F2307398 | Certificate of Analysis | May 08, 2023 | E288545 |
F2307401 | Certificate of Analysis | May 08, 2023 | E288545 |
F2307403 | Certificate of Analysis | May 08, 2023 | E288545 |
F2308065 | Certificate of Analysis | May 08, 2023 | E288545 |
F2308070 | Certificate of Analysis | May 08, 2023 | E288545 |
F2308071 | Certificate of Analysis | May 08, 2023 | E288545 |
F2309405 | Certificate of Analysis | May 08, 2023 | E288545 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 8.71, Max Conc. mM: 20 |
---|
1. Gado F, Di Cesare Mannelli L, Lucarini E, Bertini S, Cappelli E, Digiacomo M, Stevenson LA, Macchia M, Tuccinardi T, Ghelardini C et al.. (2019) Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief.. J Med Chem, 62 (1): (276-287). [PMID:29990428] [10.1021/op500134e] |